- Home
- CLDX vs OCUL Comparison
CLDX vs OCUL Comparison
Compare CLDX & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | OCUL |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CLDX | OCUL |
|---|---|---|
| Price | $33.29 | $9.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $46.60 | $23.56 |
| AVG Volume (30 Days) | 725.4K | ★ 2.8M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,743,000.00 | $1,990,000.00 |
| Revenue This Year | $111.39 | $7.93 |
| Revenue Next Year | $235.85 | $96.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 87.78 | 3.48 |
| 52 Week Low | $18.20 | $6.23 |
| 52 Week High | $35.83 | $16.44 |
Technical Indicators
Market Signals| Indicator | CLDX | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 53.45 | 57.14 |
| Support Level | $28.30 | $9.06 |
| Resistance Level | $35.18 | $9.91 |
| Average True Range (ATR) | 1.32 | 0.41 |
| MACD | -0.14 | 0.03 |
| Stochastic Oscillator | 40.19 | 69.31 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.